ARCHIVES

NCI Hits Grant Targets, But Labs Feel The Pain Of Budget Cuts, Director Says.

This article is from The Cancer Letter archive.

Vol. 33 No. 43 | November 23, 2007

Download PDF Visit The Full Archive

Related Articles

Afinitor and Sutent Approved For Pancreatic Neuroendocrine Tumors

May 27, 2011

Scientists Lose Credibility When “Fire Alarm” Pulled Too Early, ACS’s Brawley Says.

August 1, 2008

State Cancer Incidence Report Published by NCI, CDC

November 22, 2002

Selumetinib Plus Docetaxel Effective in KRAS-Mutant Disease

January 25, 2013

Pressure Builds On President To Sign Authorization Bill; No Movement Yet On Appropriations Measure

November 8, 1985

Shubik Warns NCA Members They May Be Prober’s Next Target

May 22, 1981